Author:
Loibl Sibylle,Skacel Tomas,Nekljudova Valentina,Lück Hans Joachim,Schwenkglenks Matthias,Brodowicz Thomas,Zielinski Christoph,von Minckwitz Gunter
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference15 articles.
1. Giordano SH, Buzdar AU, Smith TL: Is breast cancer survival improving?. Cancer. 2004, 100: 44-52. 10.1002/cncr.11859.
2. Lyman GH, Dale DC, Crawford J: Incidence and predictors of low dose intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices. J Clin Onco. 2003, 21: 4524-4531. 10.1200/JCO.2003.05.002.
3. Frei E, Canellos GP: Dose: A critical factor in cancer chemotherapy. Am J Med. 1980, 69: 585-594. 10.1016/0002-9343(80)90472-6.
4. Coldman AJ, Goldie JH: Impact of dose-intense chemotherapy on the development of permanent drug resistance. Semin Oncol. 1987, 14 (Suppl 3): 29-33.
5. Norton L: Evolving: concepts in the systemic drug therapy of breast cancer. Semin Oncol. 1997, 24 (Suppl l0): 10-3-10-10.